Accounting Changes Send Schering-Plough to a Loss
29498
Despite its fourth-quarter loss, the pharmaceutical giantâs results topped Wall Street estimates, and its shares rose more than 5 percent.
710615
Schering ups '04 earnings, Yasmin sales forecasts (4:41 AM ET) LONDON (CBS.MW) -- German drugmaker Schering( SHR )(DE:717200DE:717200)said it was upping its 2004 earnings forecast on a more favorable tax rate ...
652617
Lower sales, bigger losses, and a sneaky-looking accounting change mean investors should watch their wallets.
397070
The company reported a fourth-quarter net loss of $2.58 billion,  citing a $6.1 billion charge related to transferring employees from a multi-employer pension fund.
141808
An Illinois company that has struggled since 1985 to create a safe and effective artificial blood substitute said yesterday that it had surmounted a major hurdle, but investors had their doubts, sending the shares down sharply in after-hours trading.
643031
Management is trying to turn things around, but the company's paying for past mistakes.
207911
Schering-Plough Corp.  on Monday said quarterly earnings more than doubled on growing demand for its Zetia and Vytorin cholesterol drugs and its treatments for arthritis and allergies, lifting shares 3.5 percent.
551540
YESTERDAY Close $45.95 Change -$0.51 52-WEEK High $51.50 Low $33.73 The medical research and services company Charles River Laboratories International Inc. of Wilmington said fourth-quarter profit dropped 30 percent due in large part to a year-ago provision for income taxes.
292602
Drugmaker Mylan Laboratories Inc.  posted a quarterly loss on Thursday on charges related to an acquisition, but reported adjusted profit that beat its previous forecast helped by sales of generic drugs for pain and bladder control.
441996
Turnaround from record loss is not right around the corner.
475502
The drug company posts a wider Q3 loss than a year ago.
353033
Shares plunge after company says its vein graft treatment failed to show benefit in late-stage test. CHICAGO  - Biotechnology company Corgentech Inc.
255170
The biotechnology company said it lost $916,000 in the third quarter on higher operating costs, including a $50 million charge for a patent lawsuit settlement.
726077
With its cash reserves dwindling and losses continuing to mount, The SCO Group Inc. is taking measures to cut its expenses and ensure it will have enough cash to process its lawsuit with IBM Corp, the company announced during its quarterly earnings conference call Tuesday. SCO reported a loss of $7.4 million on revenue of $11.2 million for the third quarter - a loss that was affected by the $7.2 million in legal expenses the company incurred during the quarter, which ended July 31.
433465
Medical products distributor Henry Schein Inc. lowered its financial targets for the rest of the year, citing the impact of British regulators shutting down its major supplier of flu vaccine on Tuesday.
632263
Late-stage drugs are crucial for a company beset with patent losses.
494872
Boston Scientific Corp. , the state's largest life-science company, lost $3.6 billion last year thanks to its expensive acquisition of heart-device maker Guidant Corp. , and executives said yesterday they weren't certain when sales of its most important products would begin to recover from their slump.